Lunai Bioworks Inc.

RENB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$2,819-$126,732$39,683,988,239-$7,252
Dep. & Amort.$42$33-$113,495,818$32
Deferred Tax$0$0$0$0
Stock-Based Comp.$181$898-$3,535,045,662$559
Change in WC$0$1,554$1,317$973
Other Non-Cash-$4,391$122,437-$36,035,449,563$3,129
Operating Cash Flow-$1,349-$1,811$11,774,533,424-$2,560
Investing Activities
PP&E Inv.$0$0$29,773,976$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$964-$1,464$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$545$0-$29,773,976$0
Investing Cash Flow$545$964-$1,464$0
Financing Activities
Debt Repay.$0-$6,032$3,584$2,515
Stock Issued$0$0-$280$280
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,343$6,211$0-$204
Financing Cash Flow$1,343$178$3,584$2,591
Forex Effect-$7-$162-$21$60
Net Chg. in Cash$532-$830$611$91
Supplemental Information
Beg. Cash$93$923$312$221
End Cash$625$93$923$312
Free Cash Flow-$1,349-$1,811$11,804,307,400-$2,560